Section Arrow
APYX.NASDAQ
- Apyx Medical Corp
Quotes are at least 15-min delayed:2026/11/20 17:26 EST
After Hours
Last
 2.4
0 (0.00%)
Bid
2.12
Ask
2.87
High 2.4 
Low 2.33 
Volume 6 
Regular Hours (Closed)
Last
 2.4
+0.01 (+0.42%)
Day High 
2.46 
Prev. Close
2.39 
1-M High
3.3 
Volume 
100.12K 
Bid
2.12
Ask
2.87
Day Low
2.35 
Open
2.41 
1-M Low
2.25 
Market Cap 
100.68M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.76 
20-SMA 2.68 
50-SMA 2.68 
52-W High 5.08 
52-W Low 2.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.19/-0.22
Enterprise Value
139.59M
Balance Sheet
Book Value Per Share
0.23
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
16.61M
Operating Revenue Per Share
1.13
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 41.9407 -0.0393 -0.09%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.61 -0.02 -1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.89 -0.05 -0.05%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.9699 +0.0609 +6.70%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.